© 2035 by The Clinic. Powered and secured by Wix
BIGMEDX Intelligence
Structured insight for executive decision cycles.
Monthly Global Intelligence Brief
Signal Before Scale
Subscription | Digital Download
Price: $249 per month
Each Monthly Global Intelligence Brief delivers a concise, decision-focused view of global healthcare demand, regulatory movement, and market readiness — designed for fast executive review.
What’s Included
Market Signals
Global health demand indicators
Market readiness signals across priority regions
Regulatory Movement
Key policy and regulatory developments
Executive Snapshot
Executive signal summary (CEO-ready)
High-level strategic implications
Use Case
Monthly leadership updates
Early-stage market monitoring
Identifying emerging risks and opportunities
Delivery: Digital download (PDF).
Access: Available upon purchase
Decision Intelligence Tier — Elevated
Subscription | Digital Download
Price: $499 per month
(or $5,900 annual access — optional bundle)
Structured intelligence for leadership teams making expansion, investment, and market entry decisions.
Each Monthly Executive Signal+ Brief delivers an expanded, interpretation-driven view of global healthcare demand, regulatory movement, and market readiness — structured to guide prioritization, timing, and leadership decision-making.
What’s Included
Strategic Depth
Deeper regional breakdown across priority markets
Competitive and positioning insights
Decision Intelligence
Signal prioritization (what to act on vs. monitor)
Market entry timing and sequencing guidance
Risk & Regulation
Regulatory impact interpretation
Scenario framing (opportunity vs. risk outlook)
Leadership Output
Executive implications for decision-making
Structured recommendations for next-step consideration
Use Case
Market entry evaluation and timing decisions
Investment and expansion prioritization
Regulatory alignment before expansion
Leadership strategy discussions
Access: Available upon purchase
Delivery: Digital download (PDF).
All intelligence is developed using verified global sources and structured for executive-level decision use.
Early signal detection for leaders tracking global healthcare shifts before expansion decisions.
Signal Awareness Tier
(or $2,900 annual access — optional bundle)
Quarterly Strategy Signal Deck
Where to Play. When to Enter. Why It Matters.
Board-Level Strategic Intelligence | 24–36 Month Outlook
Strategic Intelligence Tier
Board-Level Strategic Intelligence
Price: $2,500
(or $8,500 annual access — optional bundle)
Structured intelligence designed to guide market entry, investment prioritization, and expansion timing decisions.
Each Quarterly Strategy Signal Deck translates global market signals into a clear strategic direction — enabling leadership teams to evaluate where to play, when to enter, and how to align regulatory and competitive positioning.
Built for board-level discussions, strategic planning cycles, and investment decision-making.
What’s Included
Strategic Framework
Market prioritization framework
Risk-adjusted opportunity scoring
Market Intelligence
Global trend analysis across priority regions
Infrastructure expansion and demand signals
Regulatory & Access
Regulatory acceleration and access landscape analysis
Policy and market entry pathway considerations
Competitive Positioning
Competitive and ecosystem landscape overview
Strategic positioning insights across markets
Executive Output
20–30 slide board-ready strategy deck
Executive recommendations and decision guidance
Use Case
Board-level market entry decisions
Capital allocation across global markets
Strategic planning and expansion sequencing
Investment prioritization under uncertainty
Format: 20–30 slide Board-Ready Strategy Deck (PDF / PPT)
Access: Available upon purchase.
License: Internal leadership use (non-distributable)
Strategic Direction Tier
Strategic Direction for Expansion
Price: $5,000
(or $17,000 annual access — optional bundle)
Expanded strategic intelligence designed for leadership teams making capital allocation, market entry, and multi-region expansion decisions.
The Strategic Direction Tier builds on the SS Deck
adding deeper interpretation, expanded regional analysis Structured scenario framing — enabling leadership teams to move from insight to strategic alignment with greater precision.
Designed for executive teams requiring
a more comprehensive view of global market dynamics, regulatory timing, and competitive positioning before committing resources.
What’s Included
Expanded Strategic Framework
Enhanced market prioritization framework across multiple regions
Advanced risk-adjusted opportunity scoring
Deeper Market Intelligence
Expanded regional breakdown (2–3 priority regions per issue)
Infrastructure expansion signals and demand trajectory analysis
Regulatory & Access Interpretation
Regulatory acceleration analysis with strategic implications
Cross-market regulatory alignment considerations
Competitive Positioning
Deeper ecosystem and competitor landscape insights
Strategic positioning considerations across markets
Scenario & Risk Framing
Best-case vs. risk-case scenario modeling
Key triggers for market entry, delay, or re-evaluation
Executive Output
30–40 slide executive strategy deck
Structured executive implications and strategic direction guidance
Use Case
Board-level expansion and investment decisions
Multi-market entry planning and sequencing
Capital allocation across global opportunities
Regulatory and timing alignment across regions
Strategic risk evaluation prior to expansion
Format: 30–40 slide Executive Strategy Deck (PDF / PPT)
Access: Available upon purchase.
License: Internal leadership use (non-distributable)
This is what serious leadership teams use before making high-stakes decisions.
Executive Advisory Intelligence
Your External Strategy & Intelligence Desk
Dedicated Signal Interpretation. Executive-Level Strategic Alignment.
For leadership teams requiring deeper strategic alignment, BIGMEDX offers retainer-based advisory intelligence. This tier moves beyond signal detection to executive interpretation, prioritization, and market-entry sequencing.
Designed for companies actively preparing for international expansion or regulatory transition.
What’s Included
Customized Market Signal Analysis
Executive Strategy Calls (Monthly or Quarterly)
Region-Specific Risk Framing
Regulatory & Market Entry Alignment Guidance
Competitive Landscape Interpretation
Ongoing Intelligence Brief Integration
Investment Structure:
Starting at $10,000 per quarter
Custom engagement pricing based on scope
Transform Insights into Global Impact
Controlled Distribution. Executive-Level Access.
Access to BIGMEDX Executive Intelligence is reserved for qualified leadership teams, strategic advisors, and institutional stakeholders. All materials are proprietary and intended for internal executive review only.
Intelligence Standards & Sources
All BIGMEDX intelligence is developed using verifiable, globally recognized sources, including:
Global health authorities
Multilateral financial institutions
Regulatory agencies
Peer-reviewed health and economic data
Established industry research firms
Each report includes a Sources & Methodology section for transparency and board-level defensibility.
Licensing & Usage
Standard License
Internal executive and board use
Single legal entity
Secure digital access
Extended License (Optional)
Regional subsidiaries included
Strategy partners and investors
Internal training use
Not Permitted
Public redistribution
Resale or white-label use
External publication
BIGMEDX
BIGMEDX provides global market intelligence and strategic insight for MedTech companies navigating international expansion.
We focus on:
Chronic disease markets
Infection disease control
Surgical innovation
Wearable devices
An aging population demands
Health system readiness
Regulatory convergence
Long-term healthcare infrastructure trends
Our role is to inform decisions —and guide strategy. Implementation services are available as a separate option after the initial planning period.